Asthma death, CD8+ T cells, and viruses

Proceedings of the American Thoracic Society

Volumn 2, Issue 2, 2005, Pages 162-165

  O'Sullivan, Siobhán M ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Digital Repository of Ireland Royal Irish Academy   (Ireland)

Author keywords

Cytotoxic T lymphocytes; Fatal asthma; Virus

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; CYTOKINE;

ADENOVIRUS; ASTHMA; CELLULAR IMMUNITY; CONFERENCE PAPER; CORONAVIRUS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MODEL; DYING; FATALITY; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG BIOPSY; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS; PATHOPHYSIOLOGY; PICORNAVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; VIRUS INFECTION;

ASTHMA; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 24144482617     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200502-016AW     Document Type: Conference Paper

References (48)

1. Siegel SC. History of asthma deaths from antiquity. J Allergy Clin Immunol 1986;80:458-462.
2. World Health Organisation. Fact Sheet No. 206. Bronchial Asthma. Revised January 2000.
3. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: execuitive summary of the GINA Dissemination Committee report. Allergy 2004;58:469-478.
4. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-336.
5. Blais L, Ernst P, Bovin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158:126-132.
6. Suissa S, Ernst P. Use of anti-inflammatory therapy and asthma mortality in Japan. Eur Respir J 2003;21:101-104.
7. Centres for Disease Control. Asthma: United States 1980-1990. JAMA 1992;268:1995-1996.
8. Sly RM, O'Donnell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol 1997;78:347-354.
9. Sly RM. Continuing decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 2004;92:313-318.
10. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffrey PK. T lymphocytes and activated eosinophils in airways mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992;145:1477-1482.
11. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, Hunt LW, Gleich GJ. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-719.
12. Wark PAB, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002;19:68-75.
13. Benatar SR. Fatal Asthma. N Engl J Med 1984;53:20-25.
14. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballaerd DJ, Sachs MI. Exposure to aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-363.
15. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229.
16. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982.
17. Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997;112:591-596.
18. Rothwell RP, Rea HH, Sears MR, Beaglehole R, Gillies AJ, Holst PE, O'Donnell TV. Lessons from the national asthma mortality study: deaths in hospital. N Z Med J 1987;100:199-202.
19. Manning P, Murphy E, Clancy L, Callaghan B. Asthma mortality in the Republic of Ireland 1970-84 and an analysis of hospital deaths in a single year. Ir Med J 1987;80:406-409.
20. Picard E, Barmeir M, Schwartz S, Villa Y, Goldberg S, Virgilis D, Kerem E. Rate and place of death from asthma among different ethnic groups in Israel: national trends 1980 to 1997. Chest 2002;122:1222-1227.
21. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003;115:272-277.
22. O'Sullivan S, Cormican L, Faul JL, Ichinohe S, Johnston SL, Burke CM, Poulter LW. Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med 2001;164:560-564.
23. Macek V, Dakhama A, Hogg JC, Green FH, Rubin BK, Hegele RG. PCR detection of viral nucleic acid in fatal asthma: is the lower respiratory tract a reservoir for common viruses? Can Respir J 1999;6:37-43.
24. Watson MW, Beasley R, Holgate ST, Bardin PG. Rhinovirus is not detectable in peripheral lung tissue after asthma death. Respirology 2003;8:234-238.
25. Grunberg K, Smits HH, Timmers MC, de Klerk EPA, Dolhain RJEM. Dick EC, Hiemstra PS, Sterk PJ. Experimental rhino-virus 16 infection: effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-616.
26. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airway hyperresponsiveness. J Clin Invest 1996;4:915-924.
27. Jarjour NN, Gern JE, Kelly EAB, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000;105:1169-1177.
28. Trigg CJ, Nicholson KG, Wang JH, Ireland DC, Jordan S, Duddle JM. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic subjects. Clin Exp Allergy 1996;26:665-676.
29. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F. Johnston SL. Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-886.
30. Grünberg K, Kuijpers AP, deKlerk EPA, de Gouw HW, Kroes AC, Dick EC, Sterk PJ. Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med 1997;155:833-838.
31. Levandowski RA, Ou DW, Jackson CG. Acute phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 1986;153:743-748.
32. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999;162:4207-4211.
33. Lukacher A, Braciale V, Braciale T. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-826.
34. Allan W, Tabi Z, Cleary A, Doherty PC. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol 1990;144:3980-3986.
35. Isaacs D, Bangham CR, McMichael AJ. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987;2:769-771.
36. Matsubara T, Inoue T, Tashiro N, Katayama K, Matsuoka T, Furukawa S. Activation of peripheral blood CD8+ T cells in adenovirus infection. Pediatr Infect Dis J 2000;19:766-768.
37. Cannon MJ, Openshaw PJ, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988;168:1163-1168.
38. Mackenzie CD, Taylor PM, Askonas BA. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. Immunology 1989;67:375-381.
39. Lee SY, Kim SJ, Kwon SS, Kim YK, Moon HS, Song JS, Park SH. Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks. Ann Allergy Asthma Immunol 2001;86:659-664.
40. Faul J, Tormey V, Leonard C, Burke C, Horne S, Poulter L. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997;10:301-307.
41. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 2003;4:965-973.
42. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 2003;4:982-990.
43. Sznajer Y, Westcott JY, Wenzel SE, Mazer B, Tucci M, Toledano BJ. Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 2004;145:115-118.
44. Sampson AP, Castling DP, Green CP, Price JF. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child 1995;73:221-225.
45. van Lier RA, ten Berge IJ, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 2003;3:931-939.
46. Coyle A, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G. Virus-specific CD8+ cells can switch to interleukin-5 production and induce airway eosinophilia. J Exp Med 1995;181:1229-1233.
47. Bendelja K, Gagro A, Bace A, Lokar-Kolbas R, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G, Rabatic S. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 2000;121:332-338.
48. Roman M, Calhoun W, Hinten K, Avendano L, Simon V, Escobar A, Gaggero A, Diaz P. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-195.